The possibility of introducing a reliable assay for a quick identification and differentiation of the main species of Mycobacterium tuberculosis complex (MTBC) supports the improvement of efficient tuberculosis combating strategies worldwide. Commercially available assays are often based on cultured samples; however, due to the long cultivation time of mycobacteria, results are delayed. Developed PCR approaches have been published previously, though, when testing intricate veterinary samples, the complex composition of multiplex qPCRs frequently leads to assay failure. In order to overcome those limits, a paradigm of a three-reaction high-resolution melting (HRM) assay for the simultaneous identification and differentiation of the main members of MTBC was established. The assay is based on single nucleotide polymorphisms within gyrB and gyrA, which have been used as target for the establishment of two highly specific HRM assays (HRM assays 1 and 2) discriminating M. tuberculosis/ Mycobacterium canetti, Mycobacterium bovis/M. bovis BCG, Mycobacterium caprae/rare M. caprae/M. bovis ecotypes, Mycobacterium africanum/Mycobacterium orygis/ Mycobacterium pinnipedii/ Clade A1, Mycobacterium microti, and a rare subtype of M. canettii followed by a third HRM assay (HRM assay 3) allowing a further differentiation of M. bovis, M. bovis BCG, and a rare subtype of M. caprae/M. bovis, which is considered to be a novel ecotype.
M. microti, M. pinnipedii, M. orygis, and four further species known as animal-adapted Clade A1 (Dassie bacillus, M. mungi, Chimpanzee bacillus, and M. suricattae) (Brites et al., 2018) . Furthermore, Mycobacterium canettii is a genetically more diverse and recombinogenic organism as observed earlier (Fabre et al., 2010) , only leading to opportunistic human infections from time to time (Boritsch et al., 2016; Supply et al., 2013) . Although its similarity of the nucleotide codes to the species of MBTC, it is not considered to be part of MTBC (Brites et al., 2018) . Mycobacterium canettii is mainly limited to the horn of Africa and most of the known strains were isolated in the Republic of Djibouti (Blouin et al., 2014) . Mycobacterium tuberculosis is known to be the major source of human tuberculosis; however, numerous cases of infection with other members of the complex are known. Mycobacterium bovis and more rarely M. caprae are the causative agents for bovine tuberculosis, which is recognized to be an important zoonosis responsible for significant economic loss (Rodriguez-Campos, Smith, Boniotti, & Aranaz, 2014) . A recent study (Loiseau et al., 2019) revealed two rare M. caprae/M. bovis ecotypes with no intrinsic pyrazinamide (PZA) resistance, in contrast to the common M. bovis strains, detected in samples from Malawi (Guerra-Assunção et al., 2015) , Germany (Friedrich Loeffler Institute) (defined in this study as ecotype I), and China (Orloski, Robbe-Austerman, Stuber, Hench, & Schoenbaum, 2018 ) (defined in this study as ecotype II). These findings resulted in a proposed revision of interpretation of the GenoType MTBC test (Hain Lifescience).
In regions where tuberculosis is endemic, neonates were vaccinated with the attenuated M. bovis strain BCG. In immunocompromised children, this procedure can cause a disease pattern similar to the one of tuberculosis (Hesseling et al., 2006) . In order to evaluate a zoonotic risk of MTBC, it is important to rely on a fast and accurate method capable of identification and differentiation of the species of MTBC leading to improved programs in public health surveillance and enhanced food safety.
Various molecular assays exist to differentiate species within MTBC. Nevertheless, many approaches have several limits. Most of the methods as, for example, the commercial GenoType MTBC test are not validated for use on clinical samples (Costa, Amaro, et al., 2014; Kasai, Ezaki, & Harayama, 2000; Niemann, Harmsen, Rüsch-Gerdes, & Richter, 2000; Pinsky & Banaei, 2008; Pounder et al., 2010; Reddington et al., 2012) . Since Mycobacteria require many months to obtain considerable growth in culture, methods based on cultivated isolates require much time to determine the correct MTBC species. Other methods are very laborious (Kamerbeek et al., 1997) , require expensive equipment (Jagielski et al., 2014) , or rely on multiplex qPCR assays (Costa, Amaro, et al., 2014; Halse, Escuyer, & Musser, 2011; Pinsky & Banaei, 2008; Pounder et al., 2010; Reddington et al., 2012) . However, the complex composition of a multiplex qPCR can often lead to PCR inhibition due to intricate organ samples of animal tissues.
High-resolution melting (HRM) approaches are cheap and rapid assays, which are able to detect single nucleotide polymorphism (SNP) according to altered melting temperatures (T m ) of dissociating PCR amplicons (Vossen, Aten, Roos, & Dunnen, 2009) . A fluorescent nucleic acid dye is intercalating with the resulting PCR amplicons, which are dissociating upon increase in temperature and thus resulting in a decrease in fluorescence intensity. The determinate of T m is based on its nucleotide sequence, length, and level of GC. The userfriendly single-plex HRM assay can be completed within roughly 2 hr. Moreover, as a major advantage, HRM assays can be performed using samples directly extracted from clinical tissue. High-resolution melting assays have been used to discriminate various bacteria species (Esteves et al., 2018; Jeffery, Gasser, Steer, & Noormohammadi, 2007; Robertson et al., 2009; Stephens, Inman-Bamber, Giffard, & Huygens, 2008; Winchell, Wolff, Tiller, Bowen, & Hoffmaster, 2010) or to analyze antibiotic resistance in M. tuberculosis (Anthwal et al., 2017; Chen et al., 2011; Yadav et al., 2012) . Moreover, HRM assays have been established for differentiation of nontuberculous mycobacteria (NTM) and confining them from MTBC (Issa et al., 2014; Khosravi, Hashemzadeh, Hashemi Shahraki, & Teimoori, 2017; Perng et al., 2012) . Some studies combined HRM with multiplex qPCR assays targeting at the region of difference (RD) (Pinsky & Banaei, 2008; Pounder et al., 2010) .
We have previously reported the design and evaluation of a HRM assay (HRM assay 1) for the identification and differentiation of MTBC into three groups most relevant for veterinarians (Landolt, Stephan, & Scherrer, 2019) . In the present study, two additional HRM assays (HRM assays 2 and 3) were developed with the aim to discern the main members of MTBC. By combining HRM assays 1 and 2 targeting six SNPs on the gyrB gene, a two-step paradigm and thus completing the three-step paradigm. For most diagnostic applications, however, a combination of HRM assays 1 and 2 will be sufficient.
| MATERIAL S AND ME THODS

| Samples and reference strains
Sixty-one samples positive for MTBC were collected from 39 different animals ( 
| Culture and DNA extraction
Sample preparation, culture, and DNA extraction were conducted as described in a former study (Ghielmetti et al., 2017) . GenoType MTBC test (Hain Lifescience), spoligotyping (Ruettger et al., 2012) , and multilocus variable number tandem repeat analysis using an internationally established 24-loci panel (Supply et al., 2006) were used for species identification of cultured isolates. Standard biosecurity procedures were followed for handling of samples.
| HRM development
High-resolution melting development of assay 1 was described in a former study (Landolt et al., 2019) . The differentiation of the main members of MTBC is performed applying a paradigm of a three-reaction HRM assay based on four SNPs located on gyrB (base pair positions 675, 756, 1,410, and 1,450 [Niemann et al., 2000] and one SNP on gyrA [base pair position 1,323]). In order to extend the obtained SNP differentiation scheme with the recently described two rare ecotypes of M. caprae/M. bovis (ecotypes I and II), a rare M. canettii subtype (Loiseau et al., 2019) and the animal-adapted MTBC clades (Brites et al., 2018) , two additional SNPs on gyrB (base pair positions 1,437 and 1,439), and one SNP on gyrA (base pair position 1,359) were included in the assay design ( Figure 1 ).
| Primer of HRM assays
Primers were designed based on alignments of the available sequences of gyrB and gyrA from MTBC (GenBank accession numbers: were designed for the three-reaction HRM paradigm (Table 2) .
| qPCR and melting conditions
Each HRM assay was processed separately on a Rotor-Gene Q system (Qiagen) with the Type-it HRM PCR Kit (Qiagen). The qPCRs were performed as described previously (Landolt et al., 2019) .
High-resolution melting ramping from 76°C to 93°C was applied.
Fluorescence data were measured every 2 s at 0.1°C increments generating specific melting curves. Reference strains M. microtii ATCC 19422, M. bovis BCG Pasteur ATCC 35734, and M. tuberculosis H37Rv were used as melting curve standards and positive controls.
Additionally, for HRM assay 3, M. bovis BCG Tice ATCC 27289 was used. As a negative control, ultrapure water was included in each experiment. Rotor-Gene Q Software 2.3.1 (Qiagen) was used for data analysis to generate normalized and difference plots as described in a previous study (Landolt et al., 2019) . To prevent false-negative results possibly deriving from inhibition, clinical samples were analyzed in duplicate undiluted and in the form of a 1:5 dilution. The cultured isolates were analyzed at concentrations between 100 pg and 10 ng. TA B L E 1 MTBC-positive samples used for the development of the HRM assays 2 and 3
To investigate the intra-and interassay variability of the T m , illustrating the repeatability of the developed HRM assays, a randomly chosen subset of 22 cultured isolates and 18 clinical specimens for HRM assays 2 and 9 cultured isolates and 7 clinical specimens for HRM assay 3 were tested, respectively. The variability assays were conducted in triplicates in three single runs at three different days.
| Specificity
To check for possible nonspecific signals of HRM assays 2 and 3, 41 different NTM, Nocardia paucivorans, Escherichia coli, and
Streptococcus suis were tested (Table A2 ).
| Sensitivity
The analytical sensitivity of HRM assay 2 was measured by tripli- 
| RE SULTS
| HRM of cultured isolates
All cultured isolates tested were amplified successfully yielding a melting curve. The resulting species-specific T m (Tables 3 and 4,   Tables A3 and A4) the interassay CVs were ranging between 0.01%-0.04% and 0.11%-0.17%, respectively ( In HRM assay 2, intra-and interassay CVs were between 0.02%-0.04% and between 0.12%-0.19%, respectively ( Table 5 , Table A5 ).
| HRM of clinical samples
High-resolution melting assay 3 showed intra-assay CVs between 0.01% and 0.02% and an interassay CV of 0.04% (Table 6 , Table A4 ). 
| Specificity
| Sensitivity
For HRM assay 2, efficiencies of the qPCR were 94% for M. microti, 97% for M. bovis, 112% for M. caprae, and 91% for H37Rv ( Figure A1 ).
In HRM assay 3, efficiencies were determined to be 89% for M. bovis BCG and 103% for M. bovis ( Figure A2 ).
High-resolution melting assay 2 showed a LOD for the lowest di- 
| D ISCUSS I ON
In the present study, the establishment of a three-reaction HRM paradigm in the form of three HRM assays is described, which can which is a benefit comparing to methods, which are based on timeconsuming procedures (Kamerbeek et al., 1997) or require cultured samples (Kasai et al., 2000; Niemann et al., 2000) . An additional advantage of this three-reaction HRM paradigm aiming at different loci lays in the fact that it is an adaptive approach, which opens the possibility for individual combinations of primer pairs depending on the question raised. In case of a probable detection of M. orygis strains and therefore a desired differentiation from M. africanum, there is potential to design a further primer pair, which would allow detecting a mutation at codon 329 of gyrB (Huard et al., 2006) representing a unique SNP in M. orygis.
The only drawback of the described HRM approach compared to the Hain test is the inability to differentiate three strains originating Figure 5 ).
The three HRM assays can be performed either consecutively or in parallel since the qPCR conditions are equal. The interpretation of the three-reaction paradigm is straightforward and simple to achieve. For routine laboratories, a simple combination of HRM assays 1 and 2 will lead to a rapid detection and differentiation of the most significant agents of tuberculosis appearing worldwide.
T m ranges deriving from HRM assays are partially overlapping (Tables 3-6) . Therefore, based solely on T m it is not possible to clearly differentiate the members of MTBC. However, by transforming melting curves into normalized and difference plots using algorithms of the Rotor-Gene Q Software 2.3.1 (Qiagen), the members of MTBC can be separated into distinct groups (Figures 2-4) . Thereby, the species-specific melting profiles showed an explicit behavior. The (Table A1) Summarizing the obtained data, both HRM assays 2 and 3 showed a very good reproducibility with small variations of T m , which is demonstrated in very low values of intra-and interassay CVs. Since HRM assays 1 and 2 are proven to be 100% specific, they can be used unambiguously for the identification and differentiation of MTBC. Moreover, the assays yielded PCR efficiencies of more than 91% and 89%, respectively. The sensitivity of HRM assay 2
showing a LOD of 10 GE is adequate. The LOD of HRM assay 3 is slightly higher with a measured LOD of 100 GE. However, since the tested collective of samples did not cover species of all eight genotype groups, it is suggested to further evaluate the assay by testing a more extensive collection of isolates. isolates. Several months of cultivation time may be saved by using these potent HRM assays. Since most species within MTBC are implicated in human infections (Huard et al., 2006) , it is of advantage to have early knowledge of transmission of tuberculosis for consequently choosing an appropriate drug therapy for humans or a proper eradication strategy when dealing with veterinary samples.
| CON CLUS ION
Tuberculosis surveillance policies and public health management depend on powerful and affordable diagnostic tools such as this paradigm of a three-reaction HRM assay, which could be easily implemented in laboratories worldwide.
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